SCM
PRME icon

Sterling Capital Management’s Prime Medicine PRME Stock Holding History

Sterling Capital Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12K Sell
3,462
-2,274
-40% -$8.65K ﹤0.01% 2277
2025
Q4 		$19.9K Buy
5,736
+542
+10% +$2.41K ﹤0.01% 2230
2025
Q3 		$28.8K Buy
5,194
+3,618
+230% +$14.7K ﹤0.01% 1978
2025
Q2 		$3.89K Buy
1,576
+1,518
+2,617% +$2.34K ﹤0.01% 2649
2025
Q1 		$115 Hold
58
– – ﹤0.01% 3132
2024
Q4 		$169 Hold
58
– – ﹤0.01% 3133
2024
Q3 		$224 Buy
+58
New +$269 ﹤0.01% 3098

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Sterling Capital Management's PRME Position: Q1 2026 in Review

Sterling Capital Management reduced its Prime Medicine (PRME) stake by 40% in Q1 2026, selling an estimated $8.65K and leaving 3,462 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #2277.

Sterling Capital Management first reported a position in PRME in Q3 2024 and has held it in 7 quarters since. The position peaked at $28.8K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Sterling Capital Management held 3,462 shares of Prime Medicine worth $12K as of Q1 2026.
  • Sterling Capital Management sold 2,274 Prime Medicine shares in Q1 2026, an estimated $8.65K.
  • Prime Medicine made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2277 holding.
  • Sterling Capital Management first reported a position in Prime Medicine in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Prime Medicine position peaked at $28.8K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.